You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新華製藥(000756.SZ):美洛昔康膠囊通過一致性評價
格隆匯 03-27 16:52

格隆匯3月27日丨新華製藥(000756.SZ)公佈,近日,公司收到國家藥品監督管理局核准簽發的美洛昔康膠囊《藥品補充申請批准通知書》,該產品通過仿製藥質量和療效一致性評價。

美洛昔康由德國勃林格殷格翰公司研發,先後開發了片劑、膠囊等劑型,在法國、英國、瑞士、瑞典等國家上市,膠囊劑商品名Mobic。

美洛昔康是一種烯醇酸類非甾體類抗炎藥,適用於類風濕性關節炎、疼痛性骨關節炎(關節病、退行性骨關節病)的治療,屬於《國家基本醫療保險、工傷保險和生育保險藥品目錄(2020年)》乙類品種。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account